✦ LIBER ✦

O3-04-05: Clinical trials of bapineuzumab, a beta-amyloid-targeted immunotherapy in patients with mild to moderate Alzheimer's disease

✍ Scribed by Michael Grundman; Ronald Black

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O3-05-08: A randomized double-blind tria

✍ Yvonne Freund-Levi; Maria Eriksdotter Jonhagen; Tommy Cederholm; Hans Basun; Ger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

O1-05-06 Clinical data on Alzhemed™ afte

✍ Paul A. Aisen; Mariam Mehran; Ruth Poole; Isabelle Lavoie; Francine Gervais; Ric 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Results from CONNECTION: A global, Phase

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

O3-04-06: Efficacy and tolerability of S

✍ Marina Zvartau-Hind; Gareth Maher-Edwards; Jackie Hunter; Michael Gold; Gillian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB